Michelle Chapman

AP Business Writers
Latest in Home
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
May 1, 2025
Screenshot 2025 05 15 At 9 22 49 Am
Siemens Moving Varian Production from Mexico to California
May 15, 2025
I Stock 1323873733 6740aacddb365
Baxter Says IV Solution Product Inventory Has Been Restored
May 14, 2025
I Stock 1208239546
Gilead Sciences Investing $32B to Boost U.S. Biopharmaceutical Manufacturing
May 13, 2025
Related Stories
Screenshot 2025 05 15 At 9 22 49 Am
Home
Siemens Moving Varian Production from Mexico to California
I Stock 1323873733 6740aacddb365
Home
Baxter Says IV Solution Product Inventory Has Been Restored
I Stock 1208239546
Home
Gilead Sciences Investing $32B to Boost U.S. Biopharmaceutical Manufacturing
Industrial Media Unboxing Video
Sponsor Content
Industrial Media Unboxing Video
More from Michelle Chapman
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
Today in Manufacturing has a new podcast brought to you by the editors of Industrial Media. In each episode, we discuss the five biggest stories in manufacturing, and the implications they have on the industry moving forward.
May 1, 2025
Ap25091417741972
News
Bankruptcy Judge Denies J&J Settlement Plan Related to Baby Powder Containing Talc
The lawsuits filed against J&J had alleged its talcum powder caused users to develop ovarian cancer.
April 1, 2025
Ap24190480760249
News
Thanks to a $1B Gift, Most Johns Hopkins Medical Students Will No Longer Pay Tuition
There have been only a handful of previous $1 billion donations to universities in the U.S.
July 9, 2024
Ap24121461117217
Equipment
Walmart to Close its 51 Health Centers, Virtual Care Service
The retailer said "there is not a sustainable business model for us to continue."
April 30, 2024
Ap23072421431994
News
Pfizer Buys Seagen for $43B, Boosts Access to Cancer Drugs
The pharmaceutical giant said it will pay $229 in cash for each Seagen share.
March 13, 2023
The Pfizer logo is displayed on the exterior of a former Pfizer factory, on May 4, 2014, in the Brooklyn borough of New York. Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic. Both companies' boards have approved the deal, which still needs regulatory approval and approval from GBT shareholders.
Home
Pfizer Buying Spree Continues with $5.4B Hematology Deal
The company plans to have about $25 billion in sales by 2030 come from new business developments.
August 8, 2022
The Pfizer logo is displayed at the company's headquarters, Feb. 5, 2021, in New York. Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant to the largest quarterly sales in its history, Thursday, July 28, 2022.
Home
Pfizer's Comirnaty, Paxlovid Push Q2 Sales to New Heights
Pfizer maintained its outlook for full-year Comirnaty sales of approximately $32 billion and Paxlovid sales of about $22 billion.
July 28, 2022